Signet Jewelers Ltd - Company Profile
Powered by
All the data and insights you need on Signet Jewelers Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Signet Jewelers Ltd Strategy Report
- Understand Signet Jewelers Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Signet Jewelers Ltd patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
US11332520B2 | Grant | Human antibodies and binding fragments thereof to tenascin | A61K39/00; A61P19/02; C07K16/18; C07K2317/21; C07K2317/55; C07K2317/565; C12N15/63 | May 17, 2022 |
IL282201B | Grant | Anti-tenascin c antibodies and uses thereof | A61K2039/505; A61K39/3955; A61P1/04; A61P1/16; A61P11/00; A61P11/06; A61P17/00; A61P17/02; A61P17/06; A61P17/16; A61P25/00; A61P29/00; A61P3/10; A61P35/00; A61P37/02; A61P37/06; A61P9/00; A61P9/10; C07K14/78; C07K16/18; C07K16/28; C07K2317/33; C07K2317/55; C07K2317/56; C07K2317/565; C07K2317/567; C07K2317/76; C07K2317/92; C07K2319/30; G01N2333/705; G01N2800/52; G01N2800/7095; G01N33/6893 | April 01, 2022 |
AU2017218535B2 | Grant | Human antibodies and binding fragments thereof to tenascin | A61K2039/505; A61K2039/54; A61K2039/545; A61K39/00; A61K39/3955; A61P1/00; A61P1/02; A61P1/04; A61P1/16; A61P1/18; A61P11/00; A61P11/06; A61P13/12; A61P15/00; A61P17/00; A61P17/02; A61P17/04; A61P17/14; A61P19/02; A61P19/08; A61P19/10; A61P21/04; A61P25/00; A61P25/02; A61P25/28; A61P27/02; A61P27/16; A61P29/00; A61P3/06; A61P3/10; A61P35/00; A61P35/04; A61P37/02; A61P37/06; A61P37/08; A61P5/00; A61P5/38; A61P7/04; A61P7/06; A61P9/00; A61P9/10; A61P9/14; C07K16/18; C07K2317/21; C07K2317/33; C07K2317/55; C07K2317/565; C07K2317/76; C07K2317/92; C12N15/63; G01N2333/435; G01N2800/24; G01N2800/52; G01N33/6893; Y02A50/30 | March 31, 2022 |
US20210355201A1 | Application | ANTI-TENASCIN C ANTIBODIES AND USES THEREOF | A61K2039/505; A61K39/3955; A61P1/04; A61P1/16; A61P11/00; A61P11/06; A61P17/00; A61P17/02; A61P17/06; A61P17/16; A61P25/00; A61P29/00; A61P3/10; A61P35/00; A61P37/02; A61P37/06; A61P9/00; A61P9/10; C07K14/78; C07K16/18; C07K2317/33; C07K2317/55; C07K2317/56; C07K2317/565; C07K2317/567; C07K2317/76; C07K2317/92; C07K2319/30; G01N33/6893 | November 18, 2021 |
CN113583121A | Application | ANTI-TENASCIN C ANTIBODIES AND USES THEREOF | A61K2039/505; A61K39/3955; A61P1/04; A61P1/16; A61P11/00; A61P11/06; A61P17/00; A61P17/02; A61P17/06; A61P17/16; A61P25/00; A61P29/00; A61P3/10; A61P35/00; A61P37/02; A61P37/06; A61P9/00; A61P9/10; C07K14/78; C07K16/18; C07K16/28; C07K2317/33; C07K2317/55; C07K2317/56; C07K2317/565; C07K2317/567; C07K2317/76; C07K2317/92; C07K2319/30; G01N2333/705; G01N2800/52; G01N2800/7095; G01N33/6893 | November 02, 2021 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward